nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—ABCB1—esophageal cancer	0.401	1	CbGaD
Sertraline—CYP2C9—Capecitabine—esophageal cancer	0.0506	0.307	CbGbCtD
Sertraline—CYP2B6—Cisplatin—esophageal cancer	0.0483	0.292	CbGbCtD
Sertraline—CYP2C9—Cisplatin—esophageal cancer	0.0255	0.154	CbGbCtD
Sertraline—ABCB1—Cisplatin—esophageal cancer	0.0247	0.15	CbGbCtD
Sertraline—ABCB1—Methotrexate—esophageal cancer	0.0161	0.0973	CbGbCtD
Sertraline—Gastritis—Capecitabine—esophageal cancer	0.000499	0.00227	CcSEcCtD
Sertraline—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000497	0.00226	CcSEcCtD
Sertraline—Muscular weakness—Capecitabine—esophageal cancer	0.000497	0.00226	CcSEcCtD
Sertraline—Eye disorder—Cisplatin—esophageal cancer	0.000494	0.00225	CcSEcCtD
Sertraline—Tinnitus—Cisplatin—esophageal cancer	0.000493	0.00224	CcSEcCtD
Sertraline—Lymphadenopathy—Methotrexate—esophageal cancer	0.000492	0.00224	CcSEcCtD
Sertraline—Flushing—Cisplatin—esophageal cancer	0.000491	0.00223	CcSEcCtD
Sertraline—Cardiac disorder—Cisplatin—esophageal cancer	0.000491	0.00223	CcSEcCtD
Sertraline—Abdominal distension—Capecitabine—esophageal cancer	0.00049	0.00223	CcSEcCtD
Sertraline—Dysphagia—Capecitabine—esophageal cancer	0.000487	0.00222	CcSEcCtD
Sertraline—Diabetes mellitus—Methotrexate—esophageal cancer	0.000482	0.00219	CcSEcCtD
Sertraline—Bronchospasm—Capecitabine—esophageal cancer	0.000479	0.00218	CcSEcCtD
Sertraline—Polyuria—Methotrexate—esophageal cancer	0.000478	0.00217	CcSEcCtD
Sertraline—Photosensitivity—Methotrexate—esophageal cancer	0.000478	0.00217	CcSEcCtD
Sertraline—Immune system disorder—Cisplatin—esophageal cancer	0.000478	0.00217	CcSEcCtD
Sertraline—Mediastinal disorder—Cisplatin—esophageal cancer	0.000477	0.00217	CcSEcCtD
Sertraline—Sweating increased—Capecitabine—esophageal cancer	0.000475	0.00216	CcSEcCtD
Sertraline—Arrhythmia—Cisplatin—esophageal cancer	0.000473	0.00215	CcSEcCtD
Sertraline—Bronchitis—Capecitabine—esophageal cancer	0.000469	0.00213	CcSEcCtD
Sertraline—Alopecia—Cisplatin—esophageal cancer	0.000468	0.00213	CcSEcCtD
Sertraline—Hepatic failure—Methotrexate—esophageal cancer	0.000467	0.00212	CcSEcCtD
Sertraline—Pancytopenia—Capecitabine—esophageal cancer	0.000463	0.0021	CcSEcCtD
Sertraline—Erythema—Cisplatin—esophageal cancer	0.000461	0.0021	CcSEcCtD
Sertraline—Malnutrition—Cisplatin—esophageal cancer	0.000461	0.0021	CcSEcCtD
Sertraline—Dysuria—Capecitabine—esophageal cancer	0.000456	0.00207	CcSEcCtD
Sertraline—Renal failure acute—Methotrexate—esophageal cancer	0.000455	0.00207	CcSEcCtD
Sertraline—Flatulence—Cisplatin—esophageal cancer	0.000454	0.00206	CcSEcCtD
Sertraline—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000453	0.00206	CcSEcCtD
Sertraline—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000445	0.00202	CcSEcCtD
Sertraline—Weight increased—Capecitabine—esophageal cancer	0.000443	0.00202	CcSEcCtD
Sertraline—Muscle spasms—Cisplatin—esophageal cancer	0.000443	0.00201	CcSEcCtD
Sertraline—Weight decreased—Capecitabine—esophageal cancer	0.000441	0.00201	CcSEcCtD
Sertraline—Hyperglycaemia—Capecitabine—esophageal cancer	0.00044	0.002	CcSEcCtD
Sertraline—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000434	0.00197	CcSEcCtD
Sertraline—Depression—Capecitabine—esophageal cancer	0.000433	0.00197	CcSEcCtD
Sertraline—Tremor—Cisplatin—esophageal cancer	0.000431	0.00196	CcSEcCtD
Sertraline—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000431	0.00196	CcSEcCtD
Sertraline—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000428	0.00195	CcSEcCtD
Sertraline—Ill-defined disorder—Cisplatin—esophageal cancer	0.000427	0.00194	CcSEcCtD
Sertraline—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000426	0.00194	CcSEcCtD
Sertraline—Myocardial infarction—Capecitabine—esophageal cancer	0.000426	0.00194	CcSEcCtD
Sertraline—Anaemia—Cisplatin—esophageal cancer	0.000426	0.00194	CcSEcCtD
Sertraline—Jaundice—Capecitabine—esophageal cancer	0.000423	0.00193	CcSEcCtD
Sertraline—Stomatitis—Capecitabine—esophageal cancer	0.000423	0.00193	CcSEcCtD
Sertraline—Conjunctivitis—Capecitabine—esophageal cancer	0.000422	0.00192	CcSEcCtD
Sertraline—Osteoarthritis—Methotrexate—esophageal cancer	0.00042	0.00191	CcSEcCtD
Sertraline—Malaise—Cisplatin—esophageal cancer	0.000415	0.00189	CcSEcCtD
Sertraline—Haematuria—Capecitabine—esophageal cancer	0.000414	0.00188	CcSEcCtD
Sertraline—Leukopenia—Cisplatin—esophageal cancer	0.000412	0.00188	CcSEcCtD
Sertraline—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000411	0.00187	CcSEcCtD
Sertraline—Epistaxis—Capecitabine—esophageal cancer	0.00041	0.00186	CcSEcCtD
Sertraline—Agranulocytosis—Capecitabine—esophageal cancer	0.000405	0.00184	CcSEcCtD
Sertraline—Convulsion—Cisplatin—esophageal cancer	0.000399	0.00182	CcSEcCtD
Sertraline—Mood swings—Methotrexate—esophageal cancer	0.000398	0.00181	CcSEcCtD
Sertraline—Bradycardia—Capecitabine—esophageal cancer	0.000397	0.00181	CcSEcCtD
Sertraline—Ataxia—Methotrexate—esophageal cancer	0.000395	0.0018	CcSEcCtD
Sertraline—Myalgia—Cisplatin—esophageal cancer	0.000392	0.00178	CcSEcCtD
Sertraline—Haemoglobin—Capecitabine—esophageal cancer	0.000392	0.00178	CcSEcCtD
Sertraline—Rhinitis—Capecitabine—esophageal cancer	0.000391	0.00178	CcSEcCtD
Sertraline—Anxiety—Cisplatin—esophageal cancer	0.000391	0.00178	CcSEcCtD
Sertraline—Haemorrhage—Capecitabine—esophageal cancer	0.00039	0.00177	CcSEcCtD
Sertraline—Hepatitis—Capecitabine—esophageal cancer	0.00039	0.00177	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000389	0.00177	CcSEcCtD
Sertraline—Hypoaesthesia—Capecitabine—esophageal cancer	0.000388	0.00177	CcSEcCtD
Sertraline—Discomfort—Cisplatin—esophageal cancer	0.000387	0.00176	CcSEcCtD
Sertraline—Pharyngitis—Capecitabine—esophageal cancer	0.000387	0.00176	CcSEcCtD
Sertraline—Urinary tract disorder—Capecitabine—esophageal cancer	0.000385	0.00175	CcSEcCtD
Sertraline—Oedema peripheral—Capecitabine—esophageal cancer	0.000384	0.00175	CcSEcCtD
Sertraline—Connective tissue disorder—Capecitabine—esophageal cancer	0.000383	0.00174	CcSEcCtD
Sertraline—Urethral disorder—Capecitabine—esophageal cancer	0.000382	0.00174	CcSEcCtD
Sertraline—Breast disorder—Methotrexate—esophageal cancer	0.000379	0.00173	CcSEcCtD
Sertraline—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000378	0.00172	CcSEcCtD
Sertraline—Oedema—Cisplatin—esophageal cancer	0.000376	0.00171	CcSEcCtD
Sertraline—Anaphylactic shock—Cisplatin—esophageal cancer	0.000376	0.00171	CcSEcCtD
Sertraline—Visual impairment—Capecitabine—esophageal cancer	0.000376	0.00171	CcSEcCtD
Sertraline—Erythema multiforme—Capecitabine—esophageal cancer	0.000369	0.00168	CcSEcCtD
Sertraline—Nervous system disorder—Cisplatin—esophageal cancer	0.000369	0.00168	CcSEcCtD
Sertraline—Thrombocytopenia—Cisplatin—esophageal cancer	0.000368	0.00167	CcSEcCtD
Sertraline—Tachycardia—Cisplatin—esophageal cancer	0.000367	0.00167	CcSEcCtD
Sertraline—Skin disorder—Cisplatin—esophageal cancer	0.000365	0.00166	CcSEcCtD
Sertraline—Eye disorder—Capecitabine—esophageal cancer	0.000364	0.00166	CcSEcCtD
Sertraline—Tinnitus—Capecitabine—esophageal cancer	0.000364	0.00165	CcSEcCtD
Sertraline—Hyperhidrosis—Cisplatin—esophageal cancer	0.000363	0.00165	CcSEcCtD
Sertraline—Flushing—Capecitabine—esophageal cancer	0.000362	0.00165	CcSEcCtD
Sertraline—Cardiac disorder—Capecitabine—esophageal cancer	0.000362	0.00165	CcSEcCtD
Sertraline—Anorexia—Cisplatin—esophageal cancer	0.000358	0.00163	CcSEcCtD
Sertraline—Pancreatitis—Methotrexate—esophageal cancer	0.000356	0.00162	CcSEcCtD
Sertraline—Angiopathy—Capecitabine—esophageal cancer	0.000354	0.00161	CcSEcCtD
Sertraline—Immune system disorder—Capecitabine—esophageal cancer	0.000352	0.0016	CcSEcCtD
Sertraline—Mediastinal disorder—Capecitabine—esophageal cancer	0.000351	0.0016	CcSEcCtD
Sertraline—Hypotension—Cisplatin—esophageal cancer	0.000351	0.0016	CcSEcCtD
Sertraline—Chills—Capecitabine—esophageal cancer	0.00035	0.00159	CcSEcCtD
Sertraline—Arrhythmia—Capecitabine—esophageal cancer	0.000348	0.00158	CcSEcCtD
Sertraline—Alopecia—Capecitabine—esophageal cancer	0.000345	0.00157	CcSEcCtD
Sertraline—Pancytopenia—Methotrexate—esophageal cancer	0.000344	0.00157	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000342	0.00156	CcSEcCtD
Sertraline—Mental disorder—Capecitabine—esophageal cancer	0.000342	0.00155	CcSEcCtD
Sertraline—Erythema—Capecitabine—esophageal cancer	0.000339	0.00154	CcSEcCtD
Sertraline—Malnutrition—Capecitabine—esophageal cancer	0.000339	0.00154	CcSEcCtD
Sertraline—Dysuria—Methotrexate—esophageal cancer	0.000339	0.00154	CcSEcCtD
Sertraline—Paraesthesia—Cisplatin—esophageal cancer	0.000338	0.00154	CcSEcCtD
Sertraline—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000337	0.00153	CcSEcCtD
Sertraline—Dyspnoea—Cisplatin—esophageal cancer	0.000335	0.00152	CcSEcCtD
Sertraline—Flatulence—Capecitabine—esophageal cancer	0.000335	0.00152	CcSEcCtD
Sertraline—Erectile dysfunction—Methotrexate—esophageal cancer	0.000334	0.00152	CcSEcCtD
Sertraline—Dysgeusia—Capecitabine—esophageal cancer	0.000332	0.00151	CcSEcCtD
Sertraline—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000331	0.00151	CcSEcCtD
Sertraline—Back pain—Capecitabine—esophageal cancer	0.000328	0.00149	CcSEcCtD
Sertraline—Decreased appetite—Cisplatin—esophageal cancer	0.000327	0.00149	CcSEcCtD
Sertraline—Muscle spasms—Capecitabine—esophageal cancer	0.000326	0.00148	CcSEcCtD
Sertraline—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000325	0.00148	CcSEcCtD
Sertraline—Drowsiness—Methotrexate—esophageal cancer	0.000323	0.00147	CcSEcCtD
Sertraline—Depression—Methotrexate—esophageal cancer	0.000322	0.00147	CcSEcCtD
Sertraline—Pain—Cisplatin—esophageal cancer	0.000321	0.00146	CcSEcCtD
Sertraline—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000321	0.00146	CcSEcCtD
Sertraline—Tremor—Capecitabine—esophageal cancer	0.000318	0.00145	CcSEcCtD
Sertraline—Stomatitis—Methotrexate—esophageal cancer	0.000315	0.00143	CcSEcCtD
Sertraline—Ill-defined disorder—Capecitabine—esophageal cancer	0.000315	0.00143	CcSEcCtD
Sertraline—Conjunctivitis—Methotrexate—esophageal cancer	0.000314	0.00143	CcSEcCtD
Sertraline—Anaemia—Capecitabine—esophageal cancer	0.000314	0.00143	CcSEcCtD
Sertraline—Sweating—Methotrexate—esophageal cancer	0.00031	0.00141	CcSEcCtD
Sertraline—Feeling abnormal—Cisplatin—esophageal cancer	0.00031	0.00141	CcSEcCtD
Sertraline—Haematuria—Methotrexate—esophageal cancer	0.000308	0.0014	CcSEcCtD
Sertraline—Malaise—Capecitabine—esophageal cancer	0.000306	0.00139	CcSEcCtD
Sertraline—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000306	0.00139	CcSEcCtD
Sertraline—Epistaxis—Methotrexate—esophageal cancer	0.000305	0.00139	CcSEcCtD
Sertraline—Vertigo—Capecitabine—esophageal cancer	0.000305	0.00139	CcSEcCtD
Sertraline—Syncope—Capecitabine—esophageal cancer	0.000304	0.00139	CcSEcCtD
Sertraline—Leukopenia—Capecitabine—esophageal cancer	0.000304	0.00138	CcSEcCtD
Sertraline—Agranulocytosis—Methotrexate—esophageal cancer	0.000302	0.00137	CcSEcCtD
Sertraline—Palpitations—Capecitabine—esophageal cancer	0.0003	0.00136	CcSEcCtD
Sertraline—Loss of consciousness—Capecitabine—esophageal cancer	0.000298	0.00136	CcSEcCtD
Sertraline—Body temperature increased—Cisplatin—esophageal cancer	0.000297	0.00135	CcSEcCtD
Sertraline—Cough—Capecitabine—esophageal cancer	0.000296	0.00135	CcSEcCtD
Sertraline—Hypertension—Capecitabine—esophageal cancer	0.000293	0.00133	CcSEcCtD
Sertraline—Haemoglobin—Methotrexate—esophageal cancer	0.000292	0.00133	CcSEcCtD
Sertraline—Haemorrhage—Methotrexate—esophageal cancer	0.00029	0.00132	CcSEcCtD
Sertraline—Hepatitis—Methotrexate—esophageal cancer	0.00029	0.00132	CcSEcCtD
Sertraline—Arthralgia—Capecitabine—esophageal cancer	0.000289	0.00131	CcSEcCtD
Sertraline—Myalgia—Capecitabine—esophageal cancer	0.000289	0.00131	CcSEcCtD
Sertraline—Chest pain—Capecitabine—esophageal cancer	0.000289	0.00131	CcSEcCtD
Sertraline—Pharyngitis—Methotrexate—esophageal cancer	0.000288	0.00131	CcSEcCtD
Sertraline—Anxiety—Capecitabine—esophageal cancer	0.000288	0.00131	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000287	0.00131	CcSEcCtD
Sertraline—Urinary tract disorder—Methotrexate—esophageal cancer	0.000287	0.0013	CcSEcCtD
Sertraline—Discomfort—Capecitabine—esophageal cancer	0.000286	0.0013	CcSEcCtD
Sertraline—Urethral disorder—Methotrexate—esophageal cancer	0.000285	0.00129	CcSEcCtD
Sertraline—Dry mouth—Capecitabine—esophageal cancer	0.000283	0.00129	CcSEcCtD
Sertraline—Visual impairment—Methotrexate—esophageal cancer	0.00028	0.00127	CcSEcCtD
Sertraline—Confusional state—Capecitabine—esophageal cancer	0.000279	0.00127	CcSEcCtD
Sertraline—Oedema—Capecitabine—esophageal cancer	0.000277	0.00126	CcSEcCtD
Sertraline—Hypersensitivity—Cisplatin—esophageal cancer	0.000277	0.00126	CcSEcCtD
Sertraline—Erythema multiforme—Methotrexate—esophageal cancer	0.000274	0.00125	CcSEcCtD
Sertraline—Shock—Capecitabine—esophageal cancer	0.000273	0.00124	CcSEcCtD
Sertraline—Nervous system disorder—Capecitabine—esophageal cancer	0.000272	0.00124	CcSEcCtD
Sertraline—Eye disorder—Methotrexate—esophageal cancer	0.000271	0.00123	CcSEcCtD
Sertraline—Thrombocytopenia—Capecitabine—esophageal cancer	0.000271	0.00123	CcSEcCtD
Sertraline—Tinnitus—Methotrexate—esophageal cancer	0.000271	0.00123	CcSEcCtD
Sertraline—Tachycardia—Capecitabine—esophageal cancer	0.00027	0.00123	CcSEcCtD
Sertraline—Asthenia—Cisplatin—esophageal cancer	0.00027	0.00123	CcSEcCtD
Sertraline—Cardiac disorder—Methotrexate—esophageal cancer	0.000269	0.00123	CcSEcCtD
Sertraline—Skin disorder—Capecitabine—esophageal cancer	0.000269	0.00122	CcSEcCtD
Sertraline—Hyperhidrosis—Capecitabine—esophageal cancer	0.000268	0.00122	CcSEcCtD
Sertraline—MAOA—neck—esophageal cancer	0.000266	0.0614	CbGeAlD
Sertraline—Anorexia—Capecitabine—esophageal cancer	0.000264	0.0012	CcSEcCtD
Sertraline—Angiopathy—Methotrexate—esophageal cancer	0.000263	0.0012	CcSEcCtD
Sertraline—Immune system disorder—Methotrexate—esophageal cancer	0.000262	0.00119	CcSEcCtD
Sertraline—Mediastinal disorder—Methotrexate—esophageal cancer	0.000262	0.00119	CcSEcCtD
Sertraline—Chills—Methotrexate—esophageal cancer	0.00026	0.00119	CcSEcCtD
Sertraline—Hypotension—Capecitabine—esophageal cancer	0.000259	0.00118	CcSEcCtD
Sertraline—Diarrhoea—Cisplatin—esophageal cancer	0.000257	0.00117	CcSEcCtD
Sertraline—Alopecia—Methotrexate—esophageal cancer	0.000257	0.00117	CcSEcCtD
Sertraline—Mental disorder—Methotrexate—esophageal cancer	0.000254	0.00116	CcSEcCtD
Sertraline—Erythema—Methotrexate—esophageal cancer	0.000253	0.00115	CcSEcCtD
Sertraline—Malnutrition—Methotrexate—esophageal cancer	0.000253	0.00115	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000252	0.00115	CcSEcCtD
Sertraline—Insomnia—Capecitabine—esophageal cancer	0.000251	0.00114	CcSEcCtD
Sertraline—Paraesthesia—Capecitabine—esophageal cancer	0.000249	0.00113	CcSEcCtD
Sertraline—Dysgeusia—Methotrexate—esophageal cancer	0.000247	0.00113	CcSEcCtD
Sertraline—Dyspnoea—Capecitabine—esophageal cancer	0.000247	0.00112	CcSEcCtD
Sertraline—Back pain—Methotrexate—esophageal cancer	0.000244	0.00111	CcSEcCtD
Sertraline—Dyspepsia—Capecitabine—esophageal cancer	0.000244	0.00111	CcSEcCtD
Sertraline—Decreased appetite—Capecitabine—esophageal cancer	0.000241	0.0011	CcSEcCtD
Sertraline—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000239	0.00109	CcSEcCtD
Sertraline—Vomiting—Cisplatin—esophageal cancer	0.000239	0.00109	CcSEcCtD
Sertraline—Fatigue—Capecitabine—esophageal cancer	0.000239	0.00109	CcSEcCtD
Sertraline—Rash—Cisplatin—esophageal cancer	0.000237	0.00108	CcSEcCtD
Sertraline—Pain—Capecitabine—esophageal cancer	0.000237	0.00108	CcSEcCtD
Sertraline—Constipation—Capecitabine—esophageal cancer	0.000237	0.00108	CcSEcCtD
Sertraline—Dermatitis—Cisplatin—esophageal cancer	0.000237	0.00108	CcSEcCtD
Sertraline—Ill-defined disorder—Methotrexate—esophageal cancer	0.000234	0.00107	CcSEcCtD
Sertraline—Anaemia—Methotrexate—esophageal cancer	0.000234	0.00106	CcSEcCtD
Sertraline—Feeling abnormal—Capecitabine—esophageal cancer	0.000228	0.00104	CcSEcCtD
Sertraline—Malaise—Methotrexate—esophageal cancer	0.000228	0.00104	CcSEcCtD
Sertraline—Vertigo—Methotrexate—esophageal cancer	0.000227	0.00103	CcSEcCtD
Sertraline—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000227	0.00103	CcSEcCtD
Sertraline—Leukopenia—Methotrexate—esophageal cancer	0.000226	0.00103	CcSEcCtD
Sertraline—Nausea—Cisplatin—esophageal cancer	0.000223	0.00102	CcSEcCtD
Sertraline—Cough—Methotrexate—esophageal cancer	0.000221	0.001	CcSEcCtD
Sertraline—Urticaria—Capecitabine—esophageal cancer	0.00022	0.001	CcSEcCtD
Sertraline—Body temperature increased—Capecitabine—esophageal cancer	0.000219	0.000996	CcSEcCtD
Sertraline—Abdominal pain—Capecitabine—esophageal cancer	0.000219	0.000996	CcSEcCtD
Sertraline—Convulsion—Methotrexate—esophageal cancer	0.000219	0.000996	CcSEcCtD
Sertraline—SIGMAR1—bronchus—esophageal cancer	0.000219	0.0504	CbGeAlD
Sertraline—Chest pain—Methotrexate—esophageal cancer	0.000215	0.000979	CcSEcCtD
Sertraline—Myalgia—Methotrexate—esophageal cancer	0.000215	0.000979	CcSEcCtD
Sertraline—Arthralgia—Methotrexate—esophageal cancer	0.000215	0.000979	CcSEcCtD
Sertraline—SIGMAR1—smooth muscle tissue—esophageal cancer	0.000214	0.0493	CbGeAlD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000214	0.000972	CcSEcCtD
Sertraline—Discomfort—Methotrexate—esophageal cancer	0.000213	0.000967	CcSEcCtD
Sertraline—MAOB—bronchus—esophageal cancer	0.000209	0.0482	CbGeAlD
Sertraline—Confusional state—Methotrexate—esophageal cancer	0.000208	0.000946	CcSEcCtD
Sertraline—Anaphylactic shock—Methotrexate—esophageal cancer	0.000206	0.000938	CcSEcCtD
Sertraline—Hypersensitivity—Capecitabine—esophageal cancer	0.000204	0.000929	CcSEcCtD
Sertraline—Nervous system disorder—Methotrexate—esophageal cancer	0.000202	0.00092	CcSEcCtD
Sertraline—Thrombocytopenia—Methotrexate—esophageal cancer	0.000202	0.000919	CcSEcCtD
Sertraline—Skin disorder—Methotrexate—esophageal cancer	0.0002	0.000911	CcSEcCtD
Sertraline—Hyperhidrosis—Methotrexate—esophageal cancer	0.000199	0.000907	CcSEcCtD
Sertraline—Asthenia—Capecitabine—esophageal cancer	0.000199	0.000904	CcSEcCtD
Sertraline—Anorexia—Methotrexate—esophageal cancer	0.000197	0.000894	CcSEcCtD
Sertraline—SIGMAR1—trachea—esophageal cancer	0.000196	0.0453	CbGeAlD
Sertraline—Pruritus—Capecitabine—esophageal cancer	0.000196	0.000892	CcSEcCtD
Sertraline—Hypotension—Methotrexate—esophageal cancer	0.000193	0.000877	CcSEcCtD
Sertraline—Diarrhoea—Capecitabine—esophageal cancer	0.00019	0.000862	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000188	0.000855	CcSEcCtD
Sertraline—Insomnia—Methotrexate—esophageal cancer	0.000187	0.000849	CcSEcCtD
Sertraline—Paraesthesia—Methotrexate—esophageal cancer	0.000185	0.000843	CcSEcCtD
Sertraline—Dyspnoea—Methotrexate—esophageal cancer	0.000184	0.000837	CcSEcCtD
Sertraline—Somnolence—Methotrexate—esophageal cancer	0.000183	0.000834	CcSEcCtD
Sertraline—Dizziness—Capecitabine—esophageal cancer	0.000183	0.000834	CcSEcCtD
Sertraline—Dyspepsia—Methotrexate—esophageal cancer	0.000182	0.000826	CcSEcCtD
Sertraline—Decreased appetite—Methotrexate—esophageal cancer	0.000179	0.000816	CcSEcCtD
Sertraline—MAOA—bronchus—esophageal cancer	0.000179	0.0412	CbGeAlD
Sertraline—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000178	0.00081	CcSEcCtD
Sertraline—Fatigue—Methotrexate—esophageal cancer	0.000178	0.000809	CcSEcCtD
Sertraline—Pain—Methotrexate—esophageal cancer	0.000176	0.000802	CcSEcCtD
Sertraline—Vomiting—Capecitabine—esophageal cancer	0.000176	0.000801	CcSEcCtD
Sertraline—Rash—Capecitabine—esophageal cancer	0.000175	0.000795	CcSEcCtD
Sertraline—Dermatitis—Capecitabine—esophageal cancer	0.000175	0.000794	CcSEcCtD
Sertraline—Headache—Capecitabine—esophageal cancer	0.000174	0.00079	CcSEcCtD
Sertraline—SLC6A4—digestive system—esophageal cancer	0.00017	0.0392	CbGeAlD
Sertraline—Feeling abnormal—Methotrexate—esophageal cancer	0.00017	0.000773	CcSEcCtD
Sertraline—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000169	0.000767	CcSEcCtD
Sertraline—Nausea—Capecitabine—esophageal cancer	0.000165	0.000749	CcSEcCtD
Sertraline—Urticaria—Methotrexate—esophageal cancer	0.000164	0.000745	CcSEcCtD
Sertraline—Abdominal pain—Methotrexate—esophageal cancer	0.000163	0.000742	CcSEcCtD
Sertraline—Body temperature increased—Methotrexate—esophageal cancer	0.000163	0.000742	CcSEcCtD
Sertraline—MAOB—digestive system—esophageal cancer	0.000162	0.0373	CbGeAlD
Sertraline—MAOA—trachea—esophageal cancer	0.00016	0.037	CbGeAlD
Sertraline—SLC6A3—lung—esophageal cancer	0.000155	0.0357	CbGeAlD
Sertraline—Hypersensitivity—Methotrexate—esophageal cancer	0.000152	0.000691	CcSEcCtD
Sertraline—Asthenia—Methotrexate—esophageal cancer	0.000148	0.000673	CcSEcCtD
Sertraline—Pruritus—Methotrexate—esophageal cancer	0.000146	0.000664	CcSEcCtD
Sertraline—CYP2B6—bronchus—esophageal cancer	0.000143	0.0329	CbGeAlD
Sertraline—SLC6A4—lung—esophageal cancer	0.000142	0.0327	CbGeAlD
Sertraline—Diarrhoea—Methotrexate—esophageal cancer	0.000141	0.000642	CcSEcCtD
Sertraline—SIGMAR1—lung—esophageal cancer	0.000141	0.0325	CbGeAlD
Sertraline—CYP2C19—digestive system—esophageal cancer	0.000141	0.0325	CbGeAlD
Sertraline—MAOA—digestive system—esophageal cancer	0.000138	0.0318	CbGeAlD
Sertraline—Dizziness—Methotrexate—esophageal cancer	0.000136	0.00062	CcSEcCtD
Sertraline—MAOB—lung—esophageal cancer	0.000135	0.0311	CbGeAlD
Sertraline—Vomiting—Methotrexate—esophageal cancer	0.000131	0.000597	CcSEcCtD
Sertraline—Rash—Methotrexate—esophageal cancer	0.00013	0.000592	CcSEcCtD
Sertraline—Dermatitis—Methotrexate—esophageal cancer	0.00013	0.000591	CcSEcCtD
Sertraline—Headache—Methotrexate—esophageal cancer	0.000129	0.000588	CcSEcCtD
Sertraline—SLC6A2—lung—esophageal cancer	0.000125	0.0288	CbGeAlD
Sertraline—Nausea—Methotrexate—esophageal cancer	0.000123	0.000557	CcSEcCtD
Sertraline—MAOA—lung—esophageal cancer	0.000115	0.0266	CbGeAlD
Sertraline—CYP1A2—digestive system—esophageal cancer	0.000115	0.0265	CbGeAlD
Sertraline—CYP2B6—digestive system—esophageal cancer	0.00011	0.0254	CbGeAlD
Sertraline—CYP2C9—digestive system—esophageal cancer	0.000109	0.0252	CbGeAlD
Sertraline—SIGMAR1—lymph node—esophageal cancer	9.65e-05	0.0222	CbGeAlD
Sertraline—CYP1A2—lung—esophageal cancer	9.61e-05	0.0222	CbGeAlD
Sertraline—MAOB—lymph node—esophageal cancer	9.23e-05	0.0213	CbGeAlD
Sertraline—CYP2B6—lung—esophageal cancer	9.21e-05	0.0212	CbGeAlD
Sertraline—SLC6A2—lymph node—esophageal cancer	8.55e-05	0.0197	CbGeAlD
Sertraline—CYP3A4—digestive system—esophageal cancer	8.33e-05	0.0192	CbGeAlD
Sertraline—CYP2D6—digestive system—esophageal cancer	8.2e-05	0.0189	CbGeAlD
Sertraline—MAOA—lymph node—esophageal cancer	7.88e-05	0.0182	CbGeAlD
Sertraline—ABCB1—epithelium—esophageal cancer	7.75e-05	0.0179	CbGeAlD
Sertraline—ABCB1—trachea—esophageal cancer	6.85e-05	0.0158	CbGeAlD
Sertraline—ABCB1—digestive system—esophageal cancer	5.9e-05	0.0136	CbGeAlD
Sertraline—ABCB1—lung—esophageal cancer	4.92e-05	0.0114	CbGeAlD
Sertraline—SLC6A3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.94e-05	0.000188	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CYP26A1—esophageal cancer	3.93e-05	0.000187	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—SLC52A3—esophageal cancer	3.93e-05	0.000187	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—BLVRB—esophageal cancer	3.93e-05	0.000187	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CA2—esophageal cancer	3.92e-05	0.000187	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CA1—esophageal cancer	3.91e-05	0.000186	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—SLC10A2—esophageal cancer	3.91e-05	0.000186	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.83e-05	0.000183	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—ALOX15—esophageal cancer	3.83e-05	0.000183	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CA2—esophageal cancer	3.83e-05	0.000182	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GSTO1—esophageal cancer	3.66e-05	0.000174	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—TPI1—esophageal cancer	3.66e-05	0.000174	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	3.65e-05	0.000174	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ADH7—esophageal cancer	3.65e-05	0.000174	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PLCE1—esophageal cancer	3.65e-05	0.000174	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CA2—esophageal cancer	3.61e-05	0.000172	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CYP1B1—esophageal cancer	3.61e-05	0.000172	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.6e-05	0.000172	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CA2—esophageal cancer	3.58e-05	0.00017	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PLCE1—esophageal cancer	3.56e-05	0.000169	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ADH7—esophageal cancer	3.56e-05	0.000169	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	3.53e-05	0.000168	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.51e-05	0.000167	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—ALDOB—esophageal cancer	3.51e-05	0.000167	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.5e-05	0.000166	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CYP19A1—esophageal cancer	3.39e-05	0.000161	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GAPDH—esophageal cancer	3.37e-05	0.000161	CbGpPWpGaD
Sertraline—ABCB1—lymph node—esophageal cancer	3.37e-05	0.00776	CbGeAlD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	3.36e-05	0.00016	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ADH7—esophageal cancer	3.35e-05	0.00016	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PLCE1—esophageal cancer	3.35e-05	0.00016	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CRABP1—esophageal cancer	3.34e-05	0.000159	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—SLC10A2—esophageal cancer	3.34e-05	0.000159	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CA1—esophageal cancer	3.34e-05	0.000159	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ADH7—esophageal cancer	3.32e-05	0.000158	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PLCE1—esophageal cancer	3.32e-05	0.000158	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.29e-05	0.000156	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ADH1B—esophageal cancer	3.2e-05	0.000152	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GNG7—esophageal cancer	3.18e-05	0.000151	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CREBBP—esophageal cancer	3.16e-05	0.000151	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ADH1B—esophageal cancer	3.12e-05	0.000149	CbGpPWpGaD
Sertraline—MAOA—Metabolism—HMOX1—esophageal cancer	3.09e-05	0.000147	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CA2—esophageal cancer	3.06e-05	0.000146	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—TYMP—esophageal cancer	3.06e-05	0.000146	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.05e-05	0.000145	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—SLC52A3—esophageal cancer	3.03e-05	0.000144	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—BLVRB—esophageal cancer	3.03e-05	0.000144	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.99e-05	0.000142	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—TYMP—esophageal cancer	2.98e-05	0.000142	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—ALDH2—esophageal cancer	2.98e-05	0.000142	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYP26A1—esophageal cancer	2.97e-05	0.000142	CbGpPWpGaD
Sertraline—MAOA—Metabolism—ABCB1—esophageal cancer	2.97e-05	0.000141	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ADH1B—esophageal cancer	2.94e-05	0.00014	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.93e-05	0.000139	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ADH1B—esophageal cancer	2.92e-05	0.000139	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP26A1—esophageal cancer	2.9e-05	0.000138	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ALOX15—esophageal cancer	2.9e-05	0.000138	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.86e-05	0.000136	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PLCE1—esophageal cancer	2.84e-05	0.000135	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ADH7—esophageal cancer	2.84e-05	0.000135	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GSTT1—esophageal cancer	2.84e-05	0.000135	CbGpPWpGaD
Sertraline—MAOB—Metabolism—NOS3—esophageal cancer	2.83e-05	0.000135	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ALOX15—esophageal cancer	2.83e-05	0.000135	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—TYMP—esophageal cancer	2.81e-05	0.000134	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.81e-05	0.000134	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CYP2A6—esophageal cancer	2.8e-05	0.000133	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—TYMP—esophageal cancer	2.79e-05	0.000133	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTO1—esophageal cancer	2.76e-05	0.000132	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—TPI1—esophageal cancer	2.76e-05	0.000132	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP26A1—esophageal cancer	2.73e-05	0.00013	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYP26A1—esophageal cancer	2.71e-05	0.000129	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—TPI1—esophageal cancer	2.7e-05	0.000128	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTO1—esophageal cancer	2.7e-05	0.000128	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ALOX15—esophageal cancer	2.66e-05	0.000127	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PTGS1—esophageal cancer	2.66e-05	0.000127	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—ENO1—esophageal cancer	2.66e-05	0.000127	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ALDOB—esophageal cancer	2.65e-05	0.000126	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ALOX15—esophageal cancer	2.64e-05	0.000126	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PSME2—esophageal cancer	2.62e-05	0.000125	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PSME1—esophageal cancer	2.62e-05	0.000125	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PTGS2—esophageal cancer	2.59e-05	0.000123	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ALDOB—esophageal cancer	2.59e-05	0.000123	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.58e-05	0.000123	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CA1—esophageal cancer	2.58e-05	0.000123	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GAPDH—esophageal cancer	2.55e-05	0.000121	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTO1—esophageal cancer	2.54e-05	0.000121	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—TPI1—esophageal cancer	2.54e-05	0.000121	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CRABP1—esophageal cancer	2.53e-05	0.00012	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—TPI1—esophageal cancer	2.52e-05	0.00012	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTO1—esophageal cancer	2.52e-05	0.00012	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ADH1B—esophageal cancer	2.49e-05	0.000119	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GAPDH—esophageal cancer	2.49e-05	0.000119	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.48e-05	0.000118	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CRABP1—esophageal cancer	2.47e-05	0.000117	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ALDOB—esophageal cancer	2.44e-05	0.000116	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ALDOB—esophageal cancer	2.42e-05	0.000115	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GNG7—esophageal cancer	2.4e-05	0.000114	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.4e-05	0.000114	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—TYMP—esophageal cancer	2.38e-05	0.000113	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CA2—esophageal cancer	2.36e-05	0.000112	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GNG7—esophageal cancer	2.35e-05	0.000112	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GAPDH—esophageal cancer	2.35e-05	0.000112	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GAPDH—esophageal cancer	2.33e-05	0.000111	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CRABP1—esophageal cancer	2.32e-05	0.000111	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYP26A1—esophageal cancer	2.32e-05	0.00011	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CRABP1—esophageal cancer	2.3e-05	0.00011	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CYP1B1—esophageal cancer	2.26e-05	0.000108	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ALOX15—esophageal cancer	2.26e-05	0.000107	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ALDH2—esophageal cancer	2.25e-05	0.000107	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GNG7—esophageal cancer	2.21e-05	0.000105	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ALDH2—esophageal cancer	2.2e-05	0.000105	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ADH7—esophageal cancer	2.19e-05	0.000104	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.19e-05	0.000104	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GNG7—esophageal cancer	2.19e-05	0.000104	CbGpPWpGaD
Sertraline—MAOB—Metabolism—EP300—esophageal cancer	2.15e-05	0.000103	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—TPI1—esophageal cancer	2.15e-05	0.000103	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTO1—esophageal cancer	2.15e-05	0.000103	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTT1—esophageal cancer	2.14e-05	0.000102	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CYP19A1—esophageal cancer	2.12e-05	0.000101	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYP2A6—esophageal cancer	2.12e-05	0.000101	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.11e-05	0.0001	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTT1—esophageal cancer	2.09e-05	9.96e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ALDH2—esophageal cancer	2.07e-05	9.87e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP2A6—esophageal cancer	2.07e-05	9.84e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ALDOB—esophageal cancer	2.06e-05	9.83e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ALDH2—esophageal cancer	2.05e-05	9.78e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ENO1—esophageal cancer	2.01e-05	9.56e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PTGS1—esophageal cancer	2.01e-05	9.56e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.99e-05	9.46e-05	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CREBBP—esophageal cancer	1.99e-05	9.45e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PSME2—esophageal cancer	1.98e-05	9.42e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PSME1—esophageal cancer	1.98e-05	9.42e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTT1—esophageal cancer	1.97e-05	9.38e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.97e-05	9.38e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PTGS1—esophageal cancer	1.96e-05	9.33e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ENO1—esophageal cancer	1.96e-05	9.33e-05	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.96e-05	9.32e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.95e-05	9.3e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP2A6—esophageal cancer	1.95e-05	9.28e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—HMOX1—esophageal cancer	1.94e-05	9.23e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.93e-05	9.2e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PSME1—esophageal cancer	1.93e-05	9.2e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PSME2—esophageal cancer	1.93e-05	9.2e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.92e-05	9.16e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.92e-05	9.16e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GNG7—esophageal cancer	1.87e-05	8.92e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—ABCB1—esophageal cancer	1.86e-05	8.86e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ENO1—esophageal cancer	1.85e-05	8.79e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PTGS1—esophageal cancer	1.85e-05	8.79e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—TYMP—esophageal cancer	1.84e-05	8.75e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.83e-05	8.72e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ENO1—esophageal cancer	1.83e-05	8.72e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PSME2—esophageal cancer	1.82e-05	8.67e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PSME1—esophageal cancer	1.82e-05	8.67e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PSME2—esophageal cancer	1.8e-05	8.59e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PSME1—esophageal cancer	1.8e-05	8.59e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.79e-05	8.51e-05	CbGpPWpGaD
Sertraline—MAOA—Metabolism—NOS3—esophageal cancer	1.78e-05	8.46e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ALDH2—esophageal cancer	1.76e-05	8.36e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.74e-05	8.3e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.73e-05	8.23e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYP1B1—esophageal cancer	1.71e-05	8.13e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTT1—esophageal cancer	1.67e-05	7.95e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.67e-05	7.94e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—TPI1—esophageal cancer	1.66e-05	7.91e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.66e-05	7.91e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYP2A6—esophageal cancer	1.65e-05	7.86e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.64e-05	7.83e-05	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PTGS2—esophageal cancer	1.63e-05	7.74e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYP19A1—esophageal cancer	1.61e-05	7.64e-05	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PIK3CA—esophageal cancer	1.59e-05	7.59e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.59e-05	7.59e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.58e-05	7.5e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP1B1—esophageal cancer	1.57e-05	7.48e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.57e-05	7.46e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ENO1—esophageal cancer	1.56e-05	7.45e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PTGS1—esophageal cancer	1.56e-05	7.45e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.56e-05	7.41e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PSME2—esophageal cancer	1.54e-05	7.34e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PSME1—esophageal cancer	1.54e-05	7.34e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.53e-05	7.3e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.52e-05	7.24e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP19A1—esophageal cancer	1.48e-05	7.03e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.46e-05	6.98e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.46e-05	6.97e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GNG7—esophageal cancer	1.45e-05	6.88e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.44e-05	6.84e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—HMOX1—esophageal cancer	1.43e-05	6.81e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ABCB1—esophageal cancer	1.41e-05	6.69e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.35e-05	6.45e-05	CbGpPWpGaD
Sertraline—MAOA—Metabolism—EP300—esophageal cancer	1.35e-05	6.44e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—HMOX1—esophageal cancer	1.35e-05	6.42e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.35e-05	6.41e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—HMOX1—esophageal cancer	1.34e-05	6.36e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYP1B1—esophageal cancer	1.33e-05	6.33e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.31e-05	6.24e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.29e-05	6.16e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.29e-05	6.14e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ABCB1—esophageal cancer	1.28e-05	6.1e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.27e-05	6.07e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYP19A1—esophageal cancer	1.25e-05	5.96e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CREBBP—esophageal cancer	1.24e-05	5.92e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ENO1—esophageal cancer	1.21e-05	5.75e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.21e-05	5.75e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PSME2—esophageal cancer	1.19e-05	5.67e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PSME1—esophageal cancer	1.19e-05	5.67e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—HMOX1—esophageal cancer	1.14e-05	5.43e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.12e-05	5.33e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—NOS3—esophageal cancer	1.11e-05	5.3e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ABCB1—esophageal cancer	1.1e-05	5.22e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.06e-05	5.06e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.03e-05	4.89e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PTGS2—esophageal cancer	1.02e-05	4.85e-05	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PIK3CA—esophageal cancer	1e-05	4.76e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.69e-06	4.62e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYP19A1—esophageal cancer	9.65e-06	4.6e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CREBBP—esophageal cancer	9.4e-06	4.47e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CREBBP—esophageal cancer	9.17e-06	4.37e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—HMOX1—esophageal cancer	8.81e-06	4.19e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CREBBP—esophageal cancer	8.64e-06	4.12e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CREBBP—esophageal cancer	8.57e-06	4.08e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—EP300—esophageal cancer	8.47e-06	4.03e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ABCB1—esophageal cancer	8.45e-06	4.03e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—NOS3—esophageal cancer	8.41e-06	4.01e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.28e-06	3.94e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—NOS3—esophageal cancer	8.21e-06	3.91e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—NOS3—esophageal cancer	7.74e-06	3.68e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PTGS2—esophageal cancer	7.69e-06	3.66e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—NOS3—esophageal cancer	7.67e-06	3.65e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PTGS2—esophageal cancer	7.51e-06	3.58e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CREBBP—esophageal cancer	7.32e-06	3.49e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PTGS2—esophageal cancer	7.08e-06	3.37e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PTGS2—esophageal cancer	7.02e-06	3.34e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—NOS3—esophageal cancer	6.55e-06	3.12e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—EP300—esophageal cancer	6.4e-06	3.05e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PIK3CA—esophageal cancer	6.26e-06	2.98e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—EP300—esophageal cancer	6.25e-06	2.97e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PTGS2—esophageal cancer	6e-06	2.85e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—EP300—esophageal cancer	5.89e-06	2.8e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—EP300—esophageal cancer	5.83e-06	2.78e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CREBBP—esophageal cancer	5.65e-06	2.69e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—NOS3—esophageal cancer	5.06e-06	2.41e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—EP300—esophageal cancer	4.99e-06	2.37e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PIK3CA—esophageal cancer	4.73e-06	2.25e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.63e-06	2.2e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PIK3CA—esophageal cancer	4.62e-06	2.2e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PIK3CA—esophageal cancer	4.35e-06	2.07e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PIK3CA—esophageal cancer	4.32e-06	2.06e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—EP300—esophageal cancer	3.85e-06	1.83e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PIK3CA—esophageal cancer	3.69e-06	1.76e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.85e-06	1.36e-05	CbGpPWpGaD
